Because the TMA analysis showed that the staining intensity of CCR4 correlated with prostate cancer progression, while that of CCR2 did not, despite the fact that their intensities were correlated with each other, CCR4 may be a more powerful driver of prostate cancer migration and invasion than CCR2. This evidence concerns the gene CCR2 and prostate cancer.